Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025Annamycin is potentially a highly ...

Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today announced that data on the ...

The COMSOL Conference has always been a tremendous help to me,” said Paul Belk, fellow for Boston Scientific. “It's my best ...

Title: Characterization of KRIYA-839, an AAV-based Gene Therapy Providing Insulin and Glucokinase, in Streptozotocin-induced Diabetic Mice, B. Burch et al. (Poster Abstract 504) Date: May 13, 2025 ...

A copy of the presentation materials will be added to the " Publications ” section of the Company's website at tscan.com once the presentation has concluded. About TScan Therapeutics, Inc.

Axovia Therapeutics Ltd., a biotechnology company developing therapies to address the genetic causes of blindness and obesity, today announced that Co-Founder ...

BOSTON, April 28, 2025--nChroma Bio ("nChroma"), a genetic medicines company advancing programmable in vivo delivery to overcome the limitations of existing therapies, today announced the acceptance ...

Women using vaginal estrogen had markedly lower sepsis and death rates and fewer hospitalizations than women not using the ...

Incyte (Nasdaq: INCY) has announced that multiple abstracts highlighting data from its oncology portfolio will be presented ...

Abstract 1679, under the session ‘Drug Combination Strategies for Cancer Treatment’, showed that APG-2449, a novel focal ...

The abstract entitled “A rapid and scalable thymus organoid development method for generating functional T cells” presents progress on the development of a transplantable and scalable artificial ...

WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced presentations at the ...